(Q21257191)

19 August 2022

Thomas Siler

2

Thomas

Siler

1 reference

19 August 2022

Niyati Prasad

3

Niyati

Prasad

1 reference

19 August 2022

Damon Jack

4

Damon

Jack

1 reference

19 August 2022

Simon Piggott

5

Simon

Piggott

1 reference

19 August 2022

Roger Owen

6

Roger

Owen

1 reference

19 August 2022

Mark Higgins

7

Mark

Higgins

1 reference

19 August 2022

Benjamin Kramer

8

Benjamin

Kramer

1 reference

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

19 August 2022

language of work or name

English

0 references

publication date

2010

0 references

published in

BMC Pulmonary Medicine

0 references

volume

10

0 references

issue

1

0 references

page(s)

11

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Standardisation of spirometry

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Patient adherence in COPD.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Minimal clinically important differences in COPD lung function

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

A systematic review of the associations between dose regimens and medication compliance

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848004

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-11

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-11

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-11

In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-11

Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-11

Tolerance to bronchodilating effects of salmeterol in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-11

24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol

21 January 2018

1 reference

12 December 2020

An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)

1 reference

12 December 2020

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

12 December 2020

Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2466-10-11

1 reference

0 references

1 reference

1 reference

PubMed publication ID

20211002

1 reference